Sotera Health Company

SHC

US83601L1026

Healthcare Facilities & Services

Real-time Estimate Cboe BZX Other stock markets 01:10:40 2024-04-26 pm EDT			5-day change	1st Jan Change
11.4 ^USD	+0.66%		+3.97%	-32.43%

Apr. 04	North American Morning Briefing : Focus Turns to -2-	DJ
Apr. 03	Citigroup Upgrades Sotera Health to Buy From Neutral, Cuts Price Target to $16 From $18	MT

Sotera Health Company(NasdaqGS:SHC) added to Russell 3000E Value Index

March 19, 2021 at 12:00 am EDT

Latest news about Sotera Health Company

North American Morning Briefing : Focus Turns to -2-	Apr. 04	DJ
Citigroup Upgrades Sotera Health to Buy From Neutral, Cuts Price Target to $16 From $18	Apr. 03	MT
North American Morning Briefing : Markets Steady -2-	Mar. 26	DJ
Sotera Health Shares Rise Following Jefferies Upgrade	Mar. 25	MT
Jefferies Upgrades Sotera Health to Buy From Hold, Price Target is $15.50	Mar. 25	MT
Transcript : Sotera Health Company Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 07:30 AM	Mar. 13
Sotera Health Insider Sold Shares Worth $1,269,177, According to a Recent SEC Filing	Mar. 06	MT
Sotera Health Company and Sotera Health Holdings, LLC Enter into Amendment No. 3 to the First Lien Credit Agreement	Mar. 04	CI
Sector Update: Health Care Stocks Mixed Premarket Tuesday	Feb. 27	MT
Transcript : Sotera Health Company, Q4 2023 Earnings Call, Feb 27, 2024	Feb. 27
Sotera Health Q4 Adjusted Earnings, Net Revenue Gain; Sets 2024 Outlook; Shares Fall	Feb. 27	MT
Earnings Flash (SHC) SOTERA HEALTH SERVICES LLC Reports Q4 Revenue $310.2M, vs. Street Est of $302.2M	Feb. 27	MT
Earnings Flash (SHC) SOTERA HEALTH SERVICES LLC Posts Q4 EPS $0.26, vs. Street Est of $0.26	Feb. 27	MT
Sotera Health Company Provides Revenue Guidance for the Full-Year 2024	Feb. 27	CI
Sotera Health Company Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Sotera Health Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27	CI
Barclays Adjusts Price Target on Sotera Health to $17 From $15, Maintains Overweight Rating	Jan. 25	MT
Transcript : Sotera Health Company Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 02:15 PM	Jan. 09
Sotera Health Company Provides Preliminary Revenue Guidance for the Year 2023	Jan. 09	CI
Transcript : Sotera Health Company Presents at 5th Annual Wolfe Research Healthcare Conference 2023, Nov-14-2023 08:45 AM	Nov. 14
Sotera Health Appoints Karen Flynn to Board of Directors	Nov. 13	CI
RBC Cuts Price Target on Sotera Health to $20 From $22, Keeps Outperform Rating	Nov. 02	MT
Sector Update: Health Care Stocks Declining Wednesday Afternoon	Nov. 01	MT
Sotera Health's Shares Rise After Q3 Adjusted Earnings Fall, Net Revenue Rises; 2023 Guidance Affirmed	Nov. 01	MT
Sotera Health's Q3 Adjusted Earnings Fall, Net Revenue Rises; 2023 Guidance Affirmed	Nov. 01	MT

Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Companyâs segments include Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. The Nordion business is a provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and materials industries and for the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.

Sector

Healthcare Facilities & Services

Calendar

2024-05-02 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Sotera Health Company

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

11.32 USD

Average target price

16.75 USD

Spread / Average Target

+47.97%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
SOTERA HEALTH COMPANY	-32.43%	3.2B
CVS HEALTH CORPORATION	-14.86%	84.87B
HCA HEALTHCARE, INC.	+12.21%	83.08B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+10.92%	29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-12.76%	16.72B
FRESENIUS SE & CO. KGAA	-3.06%	16.4B
QUEST DIAGNOSTICS INCORPORATED	-2.01%	15.04B
EUROFINS SCIENTIFIC SE	-3.97%	11.88B
FRESENIUS MEDICAL CARE AG	-1.42%	11.88B
PURE HEALTH HOLDING	-31.75%	11.86B

Other Healthcare Facilities & Services